HIGHLIGHTS
- who: Top from the Laboratory of Medical Genetics, Harbin Medical University, Harbin, Heilongjiang, China have published the research work: Identification and characterization of ANO9 in stage II and III, in the Journal: (JOURNAL)
- what: The aim of this study was to investigate the role and oncogenic mechanisms of ANO9 in human CRC progression. In view of the comprehensive data presented in this study, the authors propose that low-expression of ANO9 indicates poor prognosis in stage II and II CRC patients , which contributes to identifying subsets of patients with aggressive tumors. Patients were only included . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.